278 related articles for article (PubMed ID: 28294551)
21. Impact of the National Institutes of Health Consensus Development Program on stimulating National Institutes of Health-funded research, 1998 to 2001.
Portnoy B; Miller J; Brown-Huamani K; DeVoto E
Int J Technol Assess Health Care; 2007; 23(3):343-8. PubMed ID: 17579937
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics: Chasing Perfection.
Gaedigk A
Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
[No Abstract] [Full Text] [Related]
23. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
[TBL] [Abstract][Full Text] [Related]
24. [Comment: Hurdles for comparative effectiveness research in Germany].
Sawicki PT
Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):492-5. PubMed ID: 22981025
[No Abstract] [Full Text] [Related]
25. Translational and clinical science--time for a new vision.
Zerhouni EA
N Engl J Med; 2005 Oct; 353(15):1621-3. PubMed ID: 16221788
[No Abstract] [Full Text] [Related]
26. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
Luzum JA; Pakyz RE; Elsey AR; Haidar CE; Peterson JF; Whirl-Carrillo M; Handelman SK; Palmer K; Pulley JM; Beller M; Schildcrout JS; Field JR; Weitzel KW; Cooper-DeHoff RM; Cavallari LH; O'Donnell PH; Altman RB; Pereira N; Ratain MJ; Roden DM; Embi PJ; Sadee W; Klein TE; Johnson JA; Relling MV; Wang L; Weinshilboum RM; Shuldiner AR; Freimuth RR;
Clin Pharmacol Ther; 2017 Sep; 102(3):502-510. PubMed ID: 28090649
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits.
Maranville JC; Cox NJ
Pharmacogenomics J; 2016 Aug; 16(4):388-92. PubMed ID: 26149738
[TBL] [Abstract][Full Text] [Related]
28. Public-private partnerships at the National Institutes of Health: from discovery to commercialization.
Lyles A
Clin Ther; 2003 Nov; 25(11):2900-2. PubMed ID: 14693314
[No Abstract] [Full Text] [Related]
29. Thinking outside the box: NINDS and the clinical research collaboration.
Anderson DC
Neurology; 2008 May; 70(19):1656-7. PubMed ID: 18458225
[No Abstract] [Full Text] [Related]
30. Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.
Cavallari LH; Johnson JA
Cell Rep Med; 2023 May; 4(5):101021. PubMed ID: 37084734
[TBL] [Abstract][Full Text] [Related]
31. RAND/Hartford initiative to build interdisciplinary geriatric health care research centers.
Pincus HA; Keyser DJ; Schultz DJ
Health Aff (Millwood); 2007; 26(1):279-83. PubMed ID: 17211038
[TBL] [Abstract][Full Text] [Related]
32. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
33. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics at the tipping point: challenges and opportunities.
Roden DM; Tyndale RF
Clin Pharmacol Ther; 2011 Mar; 89(3):323-7. PubMed ID: 21326256
[No Abstract] [Full Text] [Related]
35. Informationist education.
Robison RR
Med Ref Serv Q; 2008; 27(3):339-47. PubMed ID: 19042713
[TBL] [Abstract][Full Text] [Related]
36. Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).
Grabowski J
Addiction; 2010 Dec; 105(12):2044-9. PubMed ID: 20712817
[TBL] [Abstract][Full Text] [Related]
37. Integrating rare genetic variants into pharmacogenetic drug response predictions.
Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
[TBL] [Abstract][Full Text] [Related]
38. Dosing recommendations for pharmacogenetic interactions related to drug metabolism.
Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN
Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883
[TBL] [Abstract][Full Text] [Related]
39. Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.
Zur RM; Roy LM; Ito S; Beyene J; Carew C; Ungar WJ
Pharmacogenomics J; 2016 Aug; 16(4):305-11. PubMed ID: 27217052
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacogenetics: relevant aspects for the practicing veterinarian].
Jud Schefer R; Paine Kuhn C; Demuth D
Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
